Nova Patents
LU90884I2

Sevelamer hydrochloride

Abstract

The present invention relates to compositions for use in therapy, e.g. in phosphate-binding polymers which are provided for removing phosphate from the gastrointestinal tract. The polymers are orally administered, and are useful for the treatment of hyperphosphatemia.

Term

Term ended

Projected expiry passed 25 January 2022, 4.7 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

65 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims9

Priority claims
DocumentOfficeKindDate
10559193United States of AmericaA
10559193United States of AmericaA
23845894United States of AmericaA
23845894United States of AmericaA
9409060United States of AmericaW
9409060United States of AmericaW
US19930105591–––
US19940238458–––
WO1994US09060–––

Members65

Family members, oldest first
DocumentOfficeKind
CA2169356A1CanadaA1
CA2310960A1CanadaA1
CA2402590A1CanadaA1
WO9505184A2World Intellectual Property Organization (WIPO)A2
AU7560794AAustraliaA
WO9505184A3World Intellectual Property Organization (WIPO)A3
US5496545AUnited States of AmericaA
EP0716606A1European Patent Office (EPO)A1
KR960703607ARepublic of KoreaA
WO9639156A2World Intellectual Property Organization (WIPO)A2
AU5974296AAustraliaA
WO9639156A3World Intellectual Property Organization (WIPO)A3
JPH09504782AJapanA
US5667775AUnited States of AmericaA
EP0831857A2European Patent Office (EPO)A2
AU689797B2AustraliaB2
KR19990022648ARepublic of KoreaA
HK1009243A1Hong Kong, ChinaA1
JPH11512074AJapanA
EP0716606A4European Patent Office (EPO)A4
NZ271826ANew ZealandA
CA2169356CCanadaC
US6083495AUnited States of AmericaA
NZ309548ANew ZealandA
JP3113283B2JapanB2
JP2001055336AJapanA
EP0716606B1European Patent Office (EPO)B1
AT204756TAustriaT
ATE204756T1AustriaT1
EP1133989A2European Patent Office (EPO)A2
DE69428122D1GermanyD1
ES2161780T3SpainT3
DK0716606T3DenmarkT3
HK1036753A1Hong Kong, ChinaA1
PT716606EPortugalE
LU90884I2This recordLuxembourgI2
NL300080I1Netherlands (Kingdom of the)I1
DE69428122T2GermanyT2
DE10299003I1GermanyI1
MY114084AMalaysiaA
US6509013B1United States of AmericaB1
CA2310960CCanadaC
US2003133902A1United States of AmericaA1
KR100346766B1Republic of KoreaB1
EP1133989A3European Patent Office (EPO)A3
US2004191212A1United States of AmericaA1
US6858203B2United States of AmericaB2
US7014846B2United States of AmericaB2
EP1133989B1European Patent Office (EPO)B1
DE69434726D1GermanyD1
AT324900TAustriaT
ATE324900T1AustriaT1
EP1676581A2European Patent Office (EPO)A2
DE10299003I2GermanyI2
US2006171916A1United States of AmericaA1
PT1133989EPortugalE
DK1133989T3DenmarkT3
ES2260154T3SpainT3
DE69434726T2GermanyT2
US7459151B2United States of AmericaB2
EP1676581A3European Patent Office (EPO)A3
US2009226392A1United States of AmericaA1
NL300428I1Netherlands (Kingdom of the)I1
DE122009000081I1GermanyI1
LU91629I2LuxembourgI2